HCMT
ANIK icon

Highland Capital Management (Texas)’s Anika Therapeutics ANIK Stock Holding History

Highland Capital Management (Texas)’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-30,000
Closed -$1.23M – 266
2014
Q1 		$1.23M Buy
+30,000
New +$1.12M 0.05% 149

Other funds holding ANIK

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Highland Capital Management (Texas)'s ANIK Position: Q2 2014 in Review

Highland Capital Management (Texas) sold out of Anika Therapeutics (ANIK) in Q2 2014, closing a stake of 30,000 shares — an estimated $1.23M sold.

Highland Capital Management (Texas) first reported a position in ANIK in Q1 2014 and held it in 1 quarter. The position peaked at $1.23M in Q1 2014. 162 funds tracked by Wall St. Rank hold ANIK as of Q2 2014.

  • Highland Capital Management (Texas) reported no remaining Anika Therapeutics position as of Q2 2014 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 30,000 Anika Therapeutics shares in Q2 2014, an estimated $1.23M.
  • Highland Capital Management (Texas) first reported a position in Anika Therapeutics in Q1 2014 and held it in 1 quarter.
  • Highland Capital Management (Texas)'s Anika Therapeutics position peaked at $1.23M in Q1 2014.
  • 162 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2014.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2014, filed 14 Aug 2014.